Publication of the white paper “Solving neurodegeneration” Results of an innovative research collaboration

0

SAN FRANCISCO, August 11, 2022 /PRNewswire/ — The Glaucoma Research Foundation hosted a catalytic “think tank” type meeting in April 2021 in partnership with the BrightFocus Foundation and the Melza M. and Frank Theodore Barr Foundation. The virtual meeting brought together thought leaders from across the scientific community, including experts in glaucoma and Alzheimer’s disease. The conclusions of the meeting were recently published in Molecular neurodegeneration and increase opportunities for new treatments and cures for neurodegenerative diseases such as glaucoma and Alzheimer’s disease.

Currently, there is no therapy that can prevent or stop neurodegeneration or regrow healthy neurons. The full report Solving Neurodegeneration: Common Mechanisms and Strategies for New Treatmentswhich includes an extensive bibliography will serve as an important reference for researchers working on neurodegeneration.

The authors of the publication included the participants of the meeting Shane A. LiddelowPhD, Sally TemplePhD, Larry I. BenowitzPhD, Adriana DiPoloPhD, Cheryl WellingtonPhD, Jeffrey L. GoldbergMD, PhD, Zhigang HePhD, Xin Duan, PhD, Guojun BuPhD, Albert A. DavisMD, PhD, Karthik ShekharPhD, Anna La TourPhD, David C. ChanMD, PhD, M. Valeria Canto SolerPhD, John G. FlanaganPhD, FCOoptom, Preeti SubramanianPhD, Sharyn RossiPhD, Thomas M. Brunner, Diane E. BovenkampPhD, David J. CalkinsPhD and white paper author Lauren K. WarehamPhD.

The goal of the Solving Neurodegeneration Catalyst meeting was to spark new ideas and challenge conventional wisdom by drawing on cutting-edge research from each of the participating labs. Meeting sponsors and attendees aim to identify key barriers to solving neurodegeneration and regeneration, as well as key opportunities and potential game-changing ideas. By learning from each other and through the publication of this important white paper, scientists from different areas of neuroscience are helping to accelerate the search for the next generation of innovative treatments and cures.

The authors of the publication summarized: “Providing patients with effective strategies to treat or prevent neurodegenerative diseases is a monumental challenge that scientists and clinicians will increasingly face as the population ages and the incidence of the disease increases. Achieving these goals will depend on a better understanding of the common disease mechanisms across the spectrum of neurodegenerative diseases, which include diseases of the brain and by extension, the visual system.

Glaucoma Research Foundation is a national non-profit organization dedicated to finding a cure for glaucoma. BrightFocus Foundation is a non-profit association supporting research into diseases such as Alzheimer’s disease and glaucoma.

SOURCE Glaucoma Research Foundation

Share.

Comments are closed.